skip to main content
Resultados 1 2 3 4 5 next page
Refinado por: assunto: Aged remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Material Type:
Artigo
Adicionar ao Meu Espaço

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Hellmann, Matthew D ; Ciuleanu, Tudor-Eliade ; Pluzanski, Adam ; Lee, Jong Seok ; Otterson, Gregory A ; Audigier-Valette, Clarisse ; Minenza, Elisa ; Linardou, Helena ; Burgers, Sjaak ; Salman, Pamela ; Borghaei, Hossein ; Ramalingam, Suresh S ; Brahmer, Julie ; Reck, Martin ; O’Byrne, Kenneth J ; Geese, William J ; Green, George ; Chang, Han ; Szustakowski, Joseph ; Bhagavatheeswaran, Prabhu ; Healey, Diane ; Fu, Yali ; Nathan, Faith ; Paz-Ares, Luis

The New England journal of medicine, 2018-05, Vol.378 (22), p.2093-2104 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

2
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Material Type:
Artigo
Adicionar ao Meu Espaço

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Kurata, Takayasu ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Faivre-Finn, Corinne ; Reck, Martin ; Vansteenkiste, Johan ; Spigel, David R ; Wadsworth, Catherine ; Melillo, Giovanni ; Taboada, Maria ; Dennis, Phillip A ; Özgüroğlu, Mustafa

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

3
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer

Gadgeel, Shirish ; Rodríguez-Abreu, Delvys ; Speranza, Giovanna ; Esteban, Emilio ; Felip, Enriqueta ; Dómine, Manuel ; Hui, Rina ; Hochmair, Maximilian J ; Clingan, Philip ; Powell, Steven F ; Cheng, Susanna Yee-Shan ; Bischoff, Helge G ; Peled, Nir ; Grossi, Francesco ; Jennens, Ross R ; Reck, Martin ; Garon, Edward B ; Novello, Silvia ; Rubio-Viqueira, Belén ; Boyer, Michael ; Kurata, Takayasu ; Gray, Jhanelle E ; Yang, Jing ; Bas, Tuba ; Pietanza, M Catherine ; Garassino, Marina C

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1505-1517 [Periódico revisado por pares]

United States

Texto completo disponível

4
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Yokoi, Takashi ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Wadsworth, Catherine ; Melillo, Giovanni ; Jiang, Haiyi ; Huang, Yifan ; Dennis, Phillip A ; Özgüroğlu, Mustafa

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

5
Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Barlesi, F. ; Scherpereel, A. ; Gorbunova, V. ; Gervais, R. ; Vikström, A. ; Chouaid, C. ; Chella, A. ; Kim, J.H. ; Ahn, M.J. ; Reck, M. ; Pazzola, A. ; Kim, H.T. ; Aerts, J.G ; Morando, C. ; Loundou, A. ; Groen, H.J.M. ; Rittmeyer, A.

Annals of oncology, 2014-05, Vol.25 (5), p.1044-1052 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

6
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer

Reck, M. ; Kaiser, R. ; Eschbach, C. ; Stefanic, M. ; Love, J. ; Gatzemeier, U. ; Stopfer, P. ; von Pawel, J.

Annals of oncology, 2011-06, Vol.22 (6), p.1374-1381 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

7
Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

SCAGLIOTTI, Giorgio V ; KRZAKOWSKI, Maciej ; PAPAI, Zsolt S ; KARASEVA, Nina ; THONGPRASERT, Sumitra ; DALMAU PORTULAS, Elsa ; PAWEL, Joachim Von ; KE ZHANG ; SELARU, Paulina ; TYE, Lesley ; CHAO, Richard C ; GOVINDAN, Ramaswamy ; SZCZESNA, Aleksandra ; STRAUSZ, Janos ; MAKHSON, Anatoly ; RECK, Martin ; WIERZBICKI, Rafal F ; ALBERT, Istvan ; THOMAS, Michael ; ABRAO MIZIARA, Jose Elias

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2070-2078 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

8
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

Brahmer, Julie R ; Rodríguez-Abreu, Delvys ; Robinson, Andrew G ; Hui, Rina ; Csőszi, Tibor ; Fülöp, Andrea ; Gottfried, Maya ; Peled, Nir ; Tafreshi, Ali ; Cuffe, Sinead ; O'Brien, Mary ; Rao, Suman ; Hotta, Katsuyuki ; Zhang, Jin ; Lubiniecki, Gregory M ; Deitz, Anne C ; Rangwala, Reshma ; Reck, Martin

The lancet oncology, 2017-12, Vol.18 (12), p.1600-1609 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

9
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease
Material Type:
Artigo
Adicionar ao Meu Espaço

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease

Levy, Antonin ; Hendriks, Lizza E.L. ; Berghmans, Thierry ; Faivre-Finn, Corinne ; GiajLevra, Matteo ; GiajLevra, Niccolò ; Hasan, Baktiar ; Pochesci, Alessia ; Girard, Nicolas ; Greillier, Laurent ; Lantuéjoul, Sylvie ; Edwards, John ; O'Brien, Mary ; Reck, Martin ; Besse, Benjamin ; Novello, Silvia ; Dingemans, Anne-Marie C.

European journal of cancer (1990), 2019-11, Vol.122, p.109-114 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

10
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
Material Type:
Artigo
Adicionar ao Meu Espaço

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

Joerger, M. ; von Pawel, J. ; Kraff, S. ; Fischer, J.R. ; Eberhardt, W. ; Gauler, T.C. ; Mueller, L. ; Reinmuth, N. ; Reck, M. ; Kimmich, M. ; Mayer, F. ; Kopp, H.-G. ; Behringer, D.M. ; Ko, Y.-D. ; Hilger, R.A. ; Roessler, M. ; Kloft, C. ; Henrich, A. ; Moritz, B. ; Miller, M.C. ; Salamone, S.J. ; Jaehde, U.

Annals of oncology, 2016-10, Vol.27 (10), p.1895-1902 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
  1. Antes de2005  (4)
  2. 2005Até2008  (5)
  3. 2009Até2011  (6)
  4. 2012Até2015  (11)
  5. Após 2015  (15)
  6. Mais opções open sub menu

Idioma 

  1. Russo  (4)
  2. Japonês  (4)
  3. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.